• Topotecan (SKF104864): Mechanism, Evidence, and Research Uti

  2026-05-06

  Topotecan (SKF104864) is a topoisomerase I inhibitor with robust antitumor activity and defined mechanistic action in cancer research. Its unique ability to induce apoptosis and cell cycle arrest is verifiable across multiple tumor models, with well-established protocol parameters. This article consolidates atomic evidence and addresses applications, limitations, and integration tips for practitioners.

• Cisplatin (CDDP): Mechanistic Leverage for Translational Onc

  2026-05-06

  This article explores how mechanistic insights into Cisplatin-mediated DNA damage, apoptosis, and pyroptosis can strategically empower translational researchers. Drawing on new evidence for GSDME-mediated pyroptosis in gastric cancer, it delivers actionable guidance for optimizing apoptosis assays, overcoming chemoresistance, and designing robust in vitro and in vivo protocols. The discussion bridges recent findings, APExBIO's product intelligence, and competitive benchmarking to map a visionary path in cancer research.

• Canagliflozin (hemihydrate): Best Practices for Glucose Path

  2026-05-05

  This article provides practical, scenario-driven guidance for biomedical researchers using Canagliflozin (hemihydrate) (SKU C6434) in glucose metabolism and diabetes research. Drawing on validated protocols and recent literature, it addresses common laboratory challenges—such as solubility, pathway selectivity, and data interpretation—while demonstrating how SKU C6434 supports reproducible, high-sensitivity assays.

• One-step TUNEL Cy3 Kit: Precision Apoptosis Detection in Tra

  2026-05-05

  Explore how the One-step TUNEL Cy3 Apoptosis Detection Kit enables high-fidelity apoptosis detection in complex tissue and cell models. This article highlights unique methodological insights and practical assay decisions informed by cutting-edge research.

• nor-Binaltorphimine Dihydrochloride: Unlocking KOR Circuitry

  2026-05-04

  Explore the advanced utility of nor-Binaltorphimine dihydrochloride as a selective κ-opioid receptor antagonist for dissecting brain–spinal pain circuits. This article delivers a unique translational perspective that bridges molecular pharmacology with neural circuit mapping in opioid receptor signaling research.

• AICAR Phosphate (Acadesine): Precision AMPK Activation Workf

  2026-05-04

  AICAR phosphate (Acadesine) unlocks highly selective AMPK-driven apoptosis and mitophagy modulation in cancer and inflammation models. This guide reveals actionable workflows, advanced applications, and troubleshooting strategies—grounded in cutting-edge mechanistic research and APExBIO’s high-purity reagent.

• L-Ornithine in Urea Cycle Disruption: Mechanistic Insights f

  2026-05-03

  Explore the mechanistic role of L-Ornithine in urea cycle disruption and CNS toxicity, with a focus on advanced metabolic assay design. This article leverages new evidence on (S)-2,5-diaminopentanoic acid to guide cutting-edge research applications.

• Applied TUNEL Assay: Workflow, Use Cases, and Troubleshootin

  2026-05-02

  The TUNEL Apoptosis Detection Kit (DAB) from APExBIO delivers robust, reproducible DNA fragmentation detection in apoptosis research across tissue sections and cultured cells. This guide translates recent glioma research and real-world protocols into actionable workflows, ensuring precise and sensitive apoptosis assays for advanced programmed cell death studies.

• CB-5083 and p97: Strategic Disruption of Protein Homeostasis

  2026-05-02

  This article explores the mechanistic underpinnings and translational promise of CB-5083, a selective p97 inhibitor, in targeting protein homeostasis for advanced cancer research. Blending new insights from protein degradation biology, recent comparative genomics, and preclinical efficacy, it offers strategic guidance for translational researchers aiming to harness the vulnerabilities of the ubiquitin-proteasome system. Drawing from the latest peer-reviewed discoveries—including the evolutionary rewiring of p97/cGAS interplay in longevity models—this thought-leadership piece positions CB-5083 as both a scientific tool and a strategic lever for next-generation oncology therapeutics.

• MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazoliu

  2026-05-01

  Leverage MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide) for robust, reproducible measurement of cell proliferation and metabolic activity. Uncover expert-driven protocol refinements, application insights, and troubleshooting strategies that maximize the reliability of your in vitro assays with APExBIO’s high-purity reagent.

• Magnetic Chitosan-Exosome Hydrogel Restores Function in Diab

  2026-04-30

  This study introduces a magnetic chitosan nanoparticle-exosome hydrogel that markedly improves bladder function in diabetic bladder dysfunction by activating the FAK-p38 MAPK-GATA4 pathway in adipose-derived mesenchymal stromal cells. The work advances regenerative biomaterials and provides mechanistic insight into the therapeutic modulation of angiogenesis and neural repair.

• Indazole/Indole-Based Glucagon Receptor Antagonists: Synthes

  2026-04-30

  This study introduces a novel series of indazole- and indole-based glucagon receptor antagonists (GRAs), designed as potential therapeutics for type 2 diabetes mellitus (T2DM). Through structure–activity relationship (SAR) exploration and efficient synthetic routes, several compounds demonstrated strong in vitro and in vivo efficacy, advancing the search for new T2DM treatments.

• CRISPR-Cas9 Editing of LGMN Suppresses Breast Cancer Metasta

  2026-04-29

  This study demonstrates that co-delivery of Cas9 mRNA and guide RNAs targeting the LGMN gene effectively represses breast cancer cell metastasis both in vitro and in vivo. The research advances CRISPR-based therapeutic strategies by optimizing RNA synthesis and delivery, providing mechanistic insight into potential anti-metastatic interventions.

• Sodium-Induced Mitochondrial Dysfunction Drives NECSO Cell D

  2026-04-29

  Qiao et al. (2025) unveil a mechanistic link between pathological sodium influx and mitochondrial energy failure, establishing sodium overload as a direct trigger for necrosis via disruption of oxidative phosphorylation. This work highlights a critical intersection between ion homeostasis and mitochondrial metabolism with implications for disease states featuring sodium dysregulation.

• Annexin V-PE Apoptosis Detection Kit: Precision in Live-Cell

  2026-04-28

  The Annexin V-PE Apoptosis Detection Kit from APExBIO enables rapid, fixation-free apoptosis detection, delivering high sensitivity and compatibility with both flow cytometry and fluorescence microscopy. This guide explores experimental workflows, troubleshooting strategies, and actionable insights directly tied to translational cancer research.

450 records 19/30 page Previous Next First page 上5页 1617181920 下5页 Last page